BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3296724)

  • 1. Comparison of bepridil with nadolol for angina pectoris.
    Pflugfelder PW; Humen DP; O'Brien PA; Purves PD; Jablonsky G; Kostuk WJ
    Am J Cardiol; 1987 Jun; 59(15):1283-8. PubMed ID: 3296724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of bepridil for the treatment of angina pectoris: evidence for preservation of left ventricular function.
    Zusman RM; Christensen DM; Kanarek DJ; Kiess MC; Boucher CA
    Am J Cardiol; 1985 Mar; 55(7):30C-35C. PubMed ID: 3919555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bepridil on exercise tolerance in chronic stable angina: a double-blind, randomized, placebo-controlled, crossover trial.
    Hill JA; O'Brien JT; Scott E; Conti CR; Pepine CJ
    Am J Cardiol; 1984 Mar; 53(6):679-83. PubMed ID: 6367414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris.
    Shapiro W; DiBianco R; Thadani U
    Am J Cardiol; 1985 Mar; 55(7):36C-42C. PubMed ID: 3919556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy of bepridil in patients with chronic stable angina pectoris: results of a multicenter, placebo-controlled study of extended bepridil use.
    DiBianco R; Katz RJ; Chesler E; Alpert JS; Spann JF
    Am J Cardiol; 1985 Mar; 55(7):50C-54C. PubMed ID: 3919557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bepridil in patients with chronic stable angina: results of a multicenter trial.
    Hill JA; O'Brien JT; Alpert JS; Gore JM; Zusman RM; Christensen D; Boucher CA; Vetrovec G; Borer JS; Friedman C
    Circulation; 1985 Jan; 71(1):98-103. PubMed ID: 3880521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic actions of bepridil during treatment of stable angina pectoris.
    Narahara KA; Shapiro W; Weliky I; Park J
    Am J Cardiol; 1985 Mar; 55(7):55C-58C. PubMed ID: 3883742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term bepridil monotherapy for angina pectoris.
    Sharma MK; Voyles W; Prasad R; Teague SM; Thadani U
    Am J Cardiol; 1988 Jun; 61(15):1210-3. PubMed ID: 3287882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bepridil, a new antianginal agent: clinical and hemodynamic alterations during the treatment of stable angina pectoris.
    Narahara KA; Shapiro W; Weliky I; Park J
    Am J Cardiol; 1984 Jan; 53(1):29-34. PubMed ID: 6419578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative antianginal effects of bepridil and propranolol in angina pectoris.
    Parker JO; Farrell B
    Am J Cardiol; 1986 Sep; 58(6):449-52. PubMed ID: 3529909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bepridil for chronic stable angina pectoris: results of a prospective multicenter, placebo-controlled, dose-ranging study in 77 patients.
    DiBianco R; Alpert J; Katz RJ; Spann J; Chesler E; Ferri DP; Larca LJ; Costello RB; Gore JM; Eisenman MJ
    Am J Cardiol; 1984 Jan; 53(1):35-41. PubMed ID: 6362386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination propranolol and bepridil therapy in stable angina pectoris.
    Frishman WH; Charlap S; Farnham DJ; Sawin HS; Michelson EL; Crawford MH; DiBianco R; Kostis JB; Zellner SR; Michie DD
    Am J Cardiol; 1985 Mar; 55(7):43C-49C. PubMed ID: 3883741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bepridil improves left ventricular performance in patients with angina pectoris.
    Zusman RM; Higgins J; Christensen D; Boucher CA
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):474-80. PubMed ID: 7504141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and safety of bepridil and diltiazem in chronic stable angina pectoris refractory to diltiazem. The Bepridil Collaborative Study Group.
    Singh BN
    Am J Cardiol; 1991 Aug; 68(4):306-12. PubMed ID: 1858672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nadolol versus diltiazem and combination for preventing exercise-induced ischemia in severe angina pectoris.
    Miller WE; Vittitoe J; O'Rourke RA; Crawford MH
    Am J Cardiol; 1988 Sep; 62(7):372-6. PubMed ID: 3414514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bepridil hydrochloride compared with placebo in patients with stable angina pectoris.
    Narahara KA; Singh BN; Karliner JS; Corday SR; Hossack KF
    Am J Cardiol; 1992 Apr; 69(11):37D-42D. PubMed ID: 1553890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bepridil versus verapamil in stable angina pectoris--a controlled clinical trial.
    Nielsen HK; Krusell LR; Husted SE; Pluymers RJ
    Int J Cardiol; 1989 Jun; 23(3):357-64. PubMed ID: 2500401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-angina effect of the calcium antagonist bepridil in stable angina pectoris].
    Schneider W; Mehlhorn C; Kaltenbach M; Bussmann WD
    Z Kardiol; 1985 Jun; 74(6):341-7. PubMed ID: 3895761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and concomitant use of bepridil and beta blockers in the management of angina pectoris.
    Frishman WH
    Am J Cardiol; 1992 Apr; 69(11):50D-55D. PubMed ID: 1553892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of carteolol and nadolol in the treatment of stable angina pectoris.
    Luther RR; Glassman HN; Jordan DC
    J Clin Pharmacol; 1988 Jul; 28(7):634-9. PubMed ID: 3063728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.